Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-label, In-use Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

NCT06357221 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT06357221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06357221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-label, In-use Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients
Lead sponsor
Galderma R&D
Phase
Phase 4
Overall status
Completed
Start date
April 8, 2024
Completion date
July 18, 2024
Enrollment
46 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis, psoriasis